Compare American Airlines Group Inc (AAL) vs ADMA Biologics Inc (ADMA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
American Airlines Group Inc vs ADMA Biologics Inc — how do they compare? American Airlines Group Inc trades at $15.36 (market cap $10.55B), while ADMA Biologics Inc trades at $9.81 (market cap $2.22B). The key difference: American Airlines Group Inc is far larger — about 4.8× ADMA Biologics Inc's market cap, and American Airlines Group Inc is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.
| AAL | ADMA | |
|---|---|---|
Market Cap | $10.55B | $2.22B |
Sector | Industrials | Health |
52-Week High | $18.15 | $20.38 |
52-Week Low | $10.18 | $7.60 |
Enterprise Value | $38.51B | $2.29B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About American Airlines Group Inc
American Airlines is the world's largest airline by scheduled revenue passenger miles. The firm's major hubs are Charlotte, Chicago, Dallas/Fort Worth, Los Angeles, Miami, New York, Philadelphia, Phoenix, and Washington, D.C. After completing a major fleet renewal, the company has the youngest fleet of U.S. legacy carriers.
Read more on AAL →About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →
